Hubert Metzner
28Patents
9h-index
33Co-inventors
75Inventor score
Filing activity: Dec 22, 1997 → Dec 2, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7045601B2 | Storage-stable, liquid fibrinogen formulation | Human Necessities | 37 | Expired |
| US7276235B2 | Tissue glue with improved antiadhesive properties | Human Necessities | 32 | Expired |
| US6874657B2 | Biological sealant storage and dispensing system | Human Necessities | 31 | Expired |
| US7939632B2 | Proteolytically cleavable fusion proteins with high molar specific activity | Chemistry; Metallurgy | 26 | Active |
| US6447774B1 | Stabilized protein preparations for a tissue adhesive | Human Necessities | 16 | Expired |
| US8575104B2 | Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life | Chemistry; Metallurgy | 14 | Active |
| US7351561B2 | Thrombin preparations and process for their production | Human Necessities | 13 | Expired |
| US6204036A | Stable transglutaminase preparations and processes for their production | Human Necessities | 10 | Expired |
| US6790410B2 | Use of a hydrogen peroxide plasma sterilization method for the mild sterilization of temperature-sensitive products | Human Necessities | 10 | Expired |
| US7550567B2 | Fibrinogen purification | Human Necessities | 9 | Expired |
| US8754194B2 | Modified coagulation factors with prolonged in vivo half-life | Chemistry; Metallurgy | 9 | Active |
| US7939288B2 | Method for differentiating between factor XIII deficiency states and fibrinogen deficiency states by means of thrombelastographic techniques | Chemistry; Metallurgy | 6 | Active |
| US9956269B2 | Method for improving the stability of purified factor VIII after reconstitution | Chemistry; Metallurgy | 4 | Active |
| US10537616B2 | Method for improving the stability of purified factor VIII after reconstitution | Chemistry; Metallurgy | 4 | Active |
| US9394353B2 | Method for improving the stability of purified factor VIII after reconstitution | Chemistry; Metallurgy | 3 | Active |
| US10881717B2 | Method for improving the stability of purified Factor VIII after reconstitution | Chemistry; Metallurgy | 3 | Active |
| US9878017B2 | Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating thereto | Chemistry; Metallurgy | 2 | Active |
| US9290561B2 | Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life | Chemistry; Metallurgy | 1 | Active |
| US10688157B2 | Truncated von Willebrand factor polypeptides for treating hemophilia | Human Necessities | 1 | Active |
| US8012728B2 | Thrombin preparations and process for their production | Human Necessities | 1 | Active |
| US11510968B2 | Method for improving the stability of purified Factor VIII after reconstitution | Chemistry; Metallurgy | 0 | Active |
| US9511123B2 | Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII | Chemistry; Metallurgy | 0 | Active |
| US10238718B2 | Factor VIII formulation | Human Necessities | 0 | Active |
| US11814421B2 | Truncated von Willebrand Factor polypeptides for treating hemophilia | Chemistry; Metallurgy | 0 | Active |
| US11479578B2 | Protein purification and virus inactivation with alkyl glycosides | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.